Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer - podcast episode cover

Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer

May 25, 202315 min
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

Interview with Robert W. Holloway, MD, and Sarfraz Ahmad, PhD, authors of Clinical Activity of Olvimulogene Nanivacirepvec–Primed Immunochemotherapy in Heavily Pretreated Patients With Platinum-Resistant or Platinum-Refractory Ovarian Cancer: The Nonrandomized Phase 2 VIRO-15 Clinical Trial. Hosted by Jack West, MD.

Related Content:

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Oncolytic Viral Immunochemotherapy in Patients With Ovarian Cancer | JAMA Oncology Author Interviews podcast - Listen or read transcript on Metacast